Kuo, P.-H.; Tu, C.-Y.; Chen, C.-H.; Kao, K.-C.; Hsu, J.-Y.; Lin, M.-C.; Chong, I.-W.; Sheu, C.-C.
Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study. Biomedicines 2024, 12, 2348.
https://doi.org/10.3390/biomedicines12102348
AMA Style
Kuo P-H, Tu C-Y, Chen C-H, Kao K-C, Hsu J-Y, Lin M-C, Chong I-W, Sheu C-C.
Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study. Biomedicines. 2024; 12(10):2348.
https://doi.org/10.3390/biomedicines12102348
Chicago/Turabian Style
Kuo, Ping-Hung, Chih-Yen Tu, Chia-Hung Chen, Kuo-Chin Kao, Jeng-Yuan Hsu, Meng-Chih Lin, Inn-Wen Chong, and Chau-Chyun Sheu.
2024. "Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study" Biomedicines 12, no. 10: 2348.
https://doi.org/10.3390/biomedicines12102348
APA Style
Kuo, P.-H., Tu, C.-Y., Chen, C.-H., Kao, K.-C., Hsu, J.-Y., Lin, M.-C., Chong, I.-W., & Sheu, C.-C.
(2024). Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study. Biomedicines, 12(10), 2348.
https://doi.org/10.3390/biomedicines12102348
